NP39724 Generic and Biosimilar Cancer Medicines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£652-£3M
Sector
HEALTH
Published
27 Feb 2025
Delivery
not specified
Deadline
n/a

Related Terms

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 77 suppliers

1 buyer

35 suppliers

Description

Supply of Generic and Biosimilar Cancer Medicines to NHS Scotland.

Lot Division

1 Bendamustine Powder For Solution For Infusion

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
2 Capecitabine Tablets

Supply of Capecitabine Tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
3 Carboplatin Injections

Supply of Carboplatin Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework . Full details of Goods and volumes can be found within the ITT documents.
4 Cisplatin Injections

Supply of Cisplatin Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
5 Cyclophosphamide Injection, Powder For Reconstitution

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
6 Cytarabine Injections

Supply of Cytarabine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
7 Dacarbazine Injections

Supply of Dacarbazine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
8 Disodium Folinate Injections

Supply of Disodium Folinate Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
9 Docetaxel Concentrate For Solution For Infusion

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
10 Doxorubicin Solution For Injection Vials

Supply of Doxorubicin Solution For Injection Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
11 Fluorouracil 25MG/ML Injections

Supply of Fluorouracil Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents
12 Fluorouracil 50MG/ML Injections

Supply of Fluorouracil 50MG/ML Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
13 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents
14 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
15 Gemcitabine Powder For Solution For Infusion Vials

Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents
16 Idarubicin Hydrochloride Injection Powder For Reconstitution

Supply of Idarubicin Hydrochloride Injection Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
17 Ifosfamide Injection Powder For Reconstitution

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
18 Irinotecan Hydrochloride Injections

Supply of Irinotecan Hydrochloride Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
19 Lanreotide Injection Prefilled Syringes (unbundled - without homecare)

Supply of Lanreotide Injection Prefilled Syringes (unbundled - without homecare). The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents
20 Lanreotide Injection Prefilled Syringes (bundled - with homecare)

Supply of Lanreotide Injection Prefilled Syringes (bundled - with homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
21 Methotrexate Without Preservatives Injections

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents
22 Methotrexate Oral Solution

Supply of Methotrexate Oral Solution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
23 Oxaliplatin Vial Solution

Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
24 Paclitaxel Concentrate For Intravenous Infusion

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents
25 Temozolomide Capsules

Supply of Temozolomide Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
26 Vincristine Without Preservatives Injection

Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
27 Vinorelbine Injections

Supply of Vinorelbine Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents
28 Aprepitant Capsules

Supply of Aprepitant Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
29 Topotecan Capsules

Supply of Topotecan Capsules to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
30 Topotecan Concentrate For Solution For Infusion

Supply of Topotecan Concentrate For Solution For Infusion to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
31 Octreotide Injections

Supply of Octreotide Injections to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
32 Filgrastim Pre-Filled Syringes

Supply of Filgrastim Pre-Filled Syringes to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
33 Pemetrexed Powder For Solution For Infusion Vials

Supply of Pemetrexed Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents
34 Pemetrexed (25Mg/Ml) Solution For Infusion Vials

Supply of Pemetrexed (25Mg/Ml) Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
35 Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare)

Supply of Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants]. Full details of Goods and volumes can be found within the ITT documents.
36 Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare)

Supply of Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare) to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents
37 Etoposide Injections

Supply of Etoposide Injection to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents
38 Dasatinib Tablets

Supply of Dasatinib Tablets to NHS Scotland. The Authority intends to award this Lot as a ranked multi-supplier framework to a maximum of three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
39 Range Generic & Biosimilar Cancer Medicines (unranked)

Supply of Range of Generic & Biosimilar Medicines to NHS Scotland. The Authority intends to award this Lot as a unranked multi-supplier framework per product line to a maximum of six (6) suppliers. Full details of Goods and volumes can be found within the ITT documents.
40 Idarubicin Hydrochloride Solution For Infusion Vials

Supply of Idarubicin Hydrochloride Solution For Infusion Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
41 Range of Generic Cancer Medicines (single supplier)

Supply of Range of Generic Cancer Medicines to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.
42 Bosutinib Tablets

Supply of Bosutinib tablets to NHS Scotland. The Authority intends to award this Lot as a single supplier framework. Full details of Goods and volumes can be found within the ITT documents.
43 Paclitaxel Albumin Vials

Supply of Paclitaxel Albumin Vials to NHS Scotland. The Authority intends to award this Lot as a single supplier per product line. Full details of Goods and volumes can be found within the ITT documents.

Award Detail

1 Accord (Devon)
  • Bendamustine Powder For Solution For Infusion
  • Reference: 007352-2025-1
  • Value: £30,764
2 Accord (Devon)
  • Capecitabine Tablets
  • Reference: 007352-2025-2
  • Value: £159,229
3 Fresenius Kabi (Runcorn)
  • Carboplatin Injections
  • Reference: 007352-2025-7
  • Value: £190,471
4 Pfizer (Tadworth)
  • Cisplatin Injections
  • Reference: 007352-2025-8
  • Value: £266,998
5 Baxter Healthcare (Berkshire)
  • Cyclophosphamide Injection, Powder For Reconstitution
  • Reference: 007352-2025-9
  • Value: £69,512
6 Accord (Devon)
  • Cytarabine Injections
  • Reference: 007352-2025-10
  • Value: £26,461
7 Medac Pharma (Stirling)
  • Dacarbazine Injections
  • Reference: 007352-2025-11
  • Value: £71,718
8 Medac Pharma (Stirling)
  • Disodium Folinate Injections
  • Reference: 007352-2025-12
  • Value: £72,777
9 Accord (Devon)
  • Docetaxel Concentrate For Solution For Infusion
  • Reference: 007352-2025-13
  • Value: £70,677
10 Accord (Devon)
  • Doxorubicin Solution For Injection Vials
  • Reference: 007352-2025-14
  • Value: £14,717
11 Accord (Devon)
  • Fluorouracil 50MG/ML Injections
  • Reference: 007352-2025-15
  • Value: £75,886
12 Fresenius Kabi (Runcorn)
  • Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials
  • Reference: 007352-2025-16
  • Value: £29,968
13 Day Lewis Medical (Croydon)
  • Ifosfamide Injection Powder For Reconstitution
  • Reference: 007352-2025-18
  • Value: £461,565
14 Fresenius Kabi (Runcorn)
  • Irinotecan Hydrochloride Injections
  • Reference: 007352-2025-19
  • Value: £64,662
15 Mercury Pharmaceuticals (London)
  • Lanreotide Injection Prefilled Syringes (unbundled - without homecare)
  • Reference: 007352-2025-20
  • Value: £1,324,548 [share]
  • Awarded to group of suppliers.
16 Ipsen (London)
  • Lanreotide Injection Prefilled Syringes (unbundled - without homecare)
  • Reference: 007352-2025-20
  • Value: £1,324,548 [share]
  • Awarded to group of suppliers.
17 Ipsen (London)
  • Lanreotide Injection Prefilled Syringes (bundled - with homecare)
  • Reference: 007352-2025-21
  • Value: £681,188 [share]
  • Awarded to group of suppliers.
18 Mercury Pharmaceuticals (London)
  • Lanreotide Injection Prefilled Syringes (bundled - with homecare)
  • Reference: 007352-2025-21
  • Value: £681,188 [share]
  • Awarded to group of suppliers.
19 Medac Pharma (Stirling)
  • Methotrexate Without Preservatives Injections
  • Reference: 007352-2025-22
  • Value: £83,938
20 Rosemont Pharmaceuticals (Leeds)
  • Methotrexate Oral Solution
  • Reference: 007352-2025-23
  • Value: £9,476
21 Seacross Pharmaceuticals (London)
  • Oxaliplatin Vial Solution
  • Reference: 007352-2025-24
  • Value: £40,456
22 Fresenius Kabi (Runcorn)
  • Paclitaxel Concentrate For Intravenous Infusion
  • Reference: 007352-2025-25
  • Value: £110,289
23 Ranbaxy (London)
  • Temozolomide Capsules
  • Reference: 007352-2025-26
  • Value: £26,940
24 Teva (Castleford)
  • Vincristine Without Preservatives Injection
  • Reference: 007352-2025-27
  • Value: £24,879
25 Medac Pharma (Stirling)
  • Vinorelbine Injections
  • Reference: 007352-2025-28
  • Value: £11,323
26 Accord (Devon)
  • Topotecan Concentrate For Solution For Infusion
  • Reference: 007352-2025-30
  • Value: £1,160
27 Accord (Devon)
  • Filgrastim Pre-Filled Syringes
  • Reference: 007352-2025-32
  • Value: £517,465
28 Seacross Pharmaceuticals (London)
  • Pemetrexed Powder For Solution For Infusion Vials
  • Reference: 007352-2025-33
  • Value: £652
29 Accord (Devon)
  • Pemetrexed (25Mg/Ml) Solution For Infusion Vials
  • Reference: 007352-2025-34
  • Value: £105,174
30 Teva (Castleford)
  • Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare)
  • Reference: 007352-2025-35
  • Value: £29,694
31 Teva (Castleford)
  • Dasatinib Tablets
  • Reference: 007352-2025-37
  • Value: £79,792 [share]
  • Awarded to group of suppliers.
32 Sandoz (Surrey)
  • Dasatinib Tablets
  • Reference: 007352-2025-37
  • Value: £79,792 [share]
  • Awarded to group of suppliers.
33 Zentiva (Guildford England)
  • Dasatinib Tablets
  • Reference: 007352-2025-37
  • Value: £79,792 [share]
  • Awarded to group of suppliers.
34 MSN Labs (Letchworth Garden City)
  • Dasatinib Tablets
  • Reference: 007352-2025-37
  • Value: £79,792 [share]
  • Awarded to group of suppliers.
35 Viatris UK Healthcare (Hatfield)
  • Dasatinib Tablets
  • Reference: 007352-2025-37
  • Value: £79,792 [share]
  • Awarded to group of suppliers.
36 Stada UK Thornton & Ross (Huddersfield)
  • Dasatinib Tablets
  • Reference: 007352-2025-37
  • Value: £79,792 [share]
  • Awarded to group of suppliers.
37 Stada UK Thornton & Ross (Huddersfield)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
38 Accord (Devon)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
39 Baxter Healthcare (Berkshire)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
40 Celltrion Healthcare (Slough)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
41 DR Reddys Laboratories (Cambridge)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
42 Organon Pharma (London)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
43 Pfizer (Tadworth)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
44 Roche Products (Welwyn Garden City)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
45 Sandoz (Surrey)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
46 Seacross Pharmaceuticals (London)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
47 Tillomed Laboratories (Luton)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
48 Zentiva (Guildford England)
  • Range Generic & Biosimilar Cancer Medicines (unranked)
  • Reference: 007352-2025-38
  • Value: £1,714,852 [share]
  • Awarded to group of suppliers.
49 Pfizer (Tadworth)
  • Idarubicin Hydrochloride Solution For Infusion Vials
  • Reference: 007352-2025-39
  • Value: £26,994
50 Accord (Devon)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
51 Aspen Pharmacare (London)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
52 Aspire Pharma (Petersfield)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
53 Baxter Healthcare (Berkshire)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
54 Celix Pharma (London)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
55 Chugai Pharma (London)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
56 Cipla Eu (London)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
57 CST Pharma (Walsall)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
58 Day Lewis Medical (Croydon)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
59 DR Reddys Laboratories (Cambridge)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
60 Esteve Pharmaceuticals (Maidenhead)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
61 Flexipharm Austrading (Bourne End)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
62 Glenmark Pharmaceuticals Europe (Watford)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
63 Martindale Pharma (Romford)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
64 Medac Pharma (Stirling)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
65 Morningside Pharmaceuticals (Leicestershire)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
66 MSN Labs (Letchworth Garden City)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
67 Neon Healthcare (Hertford)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
68 Pfizer (Tadworth)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
69 Selective Supplies (Haywards Heath)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
70 Teva (Castleford)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
71 Stada UK Thornton & Ross (Huddersfield)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
72 Tillomed Laboratories (Luton)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
73 Zentiva (Guildford England)
  • Range of Generic Cancer Medicines (single supplier)
  • Reference: 007352-2025-40
  • Value: £3,432,063 [share]
  • Awarded to group of suppliers.
74 Stada UK Thornton & Ross (Huddersfield)
  • Bosutinib Tablets
  • Reference: 007352-2025-41
  • Value: £112,414
75 Stada UK Thornton & Ross (Huddersfield)
  • Paclitaxel Albumin Vials
  • Reference: 007352-2025-42
  • Value: £440,653 [share]
  • Awarded to group of suppliers.
76 Zentiva (Guildford England)
  • Paclitaxel Albumin Vials
  • Reference: 007352-2025-42
  • Value: £440,653 [share]
  • Awarded to group of suppliers.
77 Teva (Castleford)
  • Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare)
  • Reference: 007352-2025-43
  • Value: £17,607

Award Criteria

Logistics 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. Details of individual lines awarded within a specific Lot can be requested from the named person at the head of this notice. (SC Ref:790367)

Reference

  • ocds-h6vhtk-04870b
  • FTS 007352-2025

Domains